Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.

Rubatto M, Baggi A, Depenni R, Guida M, Ascierto PA, Queirolo P, Peris K, Spagnolo F, Bianchi L, De Galitiis F, Zamparini M, Proietti I, Marconcini R, Botticelli A, Barbieri V, Alfieri S, Fargnoli MC, Occelli M, Fava P, Capacchione A, Comunanza V, Bossi P, Quaglino P.

Open source

DOI
10.1111/ddg.70440
Published
2026-09-02
Container
J Dtsch Dermatol Ges
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ddg.70440,
  title = {Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.},
  author = {Rubatto M and  Baggi A and  Depenni R and  Guida M and  Ascierto PA and  Queirolo P and  Peris K and  Spagnolo F and  Bianchi L and  De Galitiis F and  Zamparini M and  Proietti I and  Marconcini R and  Botticelli A and  Barbieri V and  Alfieri S and  Fargnoli MC and  Occelli M and  Fava P and  Capacchione A and  Comunanza V and  Bossi P and  Quaglino P.},
  year = {2026},
  journal = {J Dtsch Dermatol Ges},
  doi = {10.1111/ddg.70440},
  url = {https://doi.org/10.1111/ddg.70440}
}

RIS

TY  - JOUR
TI  - Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
AU  - Rubatto M
AU  -  Baggi A
AU  -  Depenni R
AU  -  Guida M
AU  -  Ascierto PA
AU  -  Queirolo P
AU  -  Peris K
AU  -  Spagnolo F
AU  -  Bianchi L
AU  -  De Galitiis F
AU  -  Zamparini M
AU  -  Proietti I
AU  -  Marconcini R
AU  -  Botticelli A
AU  -  Barbieri V
AU  -  Alfieri S
AU  -  Fargnoli MC
AU  -  Occelli M
AU  -  Fava P
AU  -  Capacchione A
AU  -  Comunanza V
AU  -  Bossi P
AU  -  Quaglino P.
PY  - 2026
JO  - J Dtsch Dermatol Ges
DO  - 10.1111/ddg.70440
UR  - https://doi.org/10.1111/ddg.70440
ER  - 

APA

M, R., A, B., R, D., M, G., PA, A., P, Q., K, P., F, S., L, B., F, D. G., M, Z., I, P., R, M., A, B., V, B., S, A., MC, F., M, O., P, F., A, C., V, C., P, B., & P., Q. (2026). Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.. J Dtsch Dermatol Ges. https://doi.org/10.1111/ddg.70440

Source records